13 June 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
18 June 2025 - PHARMAC has declined 48 inactive funding applications so that it is clearer what medicines are currently ...
17 June 2025 - PHARMAC’s Board has appointed a new Chief Executive to lead the organisation. ...
16 June 2025 - The EMA has published a draft agenda for this week's CHMP meeting. ...
13 June 2025 - People in England will become the first in the world to receive belantamab mafodotin for this indication ...
11 June 2025 - AbbVie Korea's Epkinly (epcoritamab), a treatment for adults with relapsed or refractory diffuse large B-cell lymphoma ...
10 June 2025 - The DoH has published a revised agenda for next month's PBAC meeting. ...
9 June 2025 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
5 June 2025 - Biogen Canada is disappointed by INESSS's recommendation against listing Skyclarys (omaveloxolone), despite its therapeutic potential for ...
4 June 2025 - The DoH has published a revised agenda for last month's PBAC meeting. ...
2 June 2025 - Children immunised with the antibody nirsevimab are significantly less likely to develop RSV-related lower respiratory tract infections. ...
2 June 2025 - An indirect comparison shows a significant reduction in the monthly rate of attacks and other benefits. ...
29 May 2025 - There are significant uncertainties regarding long term efficacy of tolebrutinib; ICER estimates that treatment would achieve ...
27 May 2025 - Public comment period now open until 24 June 2025; requests to make oral comment during public ...
23 May 2025 - Positive recommendation based on Phase 3 INAVO120 data showing Itovebi (inavolisib) in combination with palbociclib and fulvestrant ...